seattle genetics inc
(SGEN:Consolidated Issue Listed on NASDAQ Global Select )
Clay B. Siegall Ph.D.
Co-Founder, Chairman, Chief Executive Officer and President, Seattle Genetics, Inc.
|Age||Total Calculated Compensation||This person is connected to 36 board members in 4 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Clay B. Siegall, Ph.D., co-founded Seattle Genetics, Inc. in 1997 and has been its Chief Executive Officer since November 2002 and President since June 2000. Dr. Siegall has nearly 20 years of experience in cancer research and therapeutic drug development. Dr. Siegall served as Executive Vice President of Seattle Genetics Inc., from December 1997 to June 2000 and Chief Scientific Officer from December 1997 to November 2002. Dr. Siegall was with the Bristol-Myers ...
21823 30th Drive SEPhone: 425-527-4000
Bothell, Washington 98021
Board Members Memberships*
Co-Founder, Chairman, Chief Executive Officer and President
Director, Chairman of Compensation Committee and Member of Audit Committee
Independent Director and Member of Compensation Committee
George Washington University
University of Maryland
|Simon E. Moroney Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Jan G. J. van de Winkel Ph.D.||Co-Founder, Chief Executive Officer and President|
|Aijaz Tobaccowalla||Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee|
|David T. Hung M.D.||Founder, Chief Executive Officer, President and Executive Director|
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$889.2K||Compensation as of Fiscal Year 2014.|